• AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

  • Nov 7 2024
  • Length: 25 mins
  • Podcast

AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

Listen for free

View show details

  • Summary

  • The ELEVATUM study exclusively enrolled historically underrepresented patients in a study assessing faricimab (Vabysmo, Genentech/Roche) for DME. Were there any surprises in the data? Jeremiah Brown, MD, MS, sits down with New Retina Radio to review the philosophy behind the ELEVATUM study, discuss the study’s findings, and preview the next phases of the trial. And Eric Schneider, MD, joins the program to discuss the findings of a pivotal study assessing home OCT (Scanly, Notal Vision) in wet AMD patients. Is home OCT equivalent to in-office OCT when it comes to visualization? And do expert graders agree with an AI algorithm’s assessments of patient’s pathology?
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about AAO '24 Late-Breakers: ELEVATUM Study and Home OCT in Wet AMD

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available